A Study to Evaluate the Pharmacokinetics and Glucodynamics of LY900014 Compared to Humalog Following a Single Dose in Patients With T2DM
Phase of Trial: Phase I
Latest Information Update: 21 Nov 2017
At a glance
- Drugs Insulin lispro (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Eli Lilly
- 15 Nov 2017 Planned End Date changed from 1 Mar 2018 to 1 Dec 2017.
- 15 Nov 2017 Planned primary completion date changed from 1 Mar 2018 to 1 Dec 2017.
- 20 Oct 2017 Status changed from not yet recruiting to recruiting.